adenocarcinoma of the prostate
Item
histologically confirmed adenocarcinoma of the prostate
boolean
C0600139 (UMLS CUI [1])
metastatic disease
Item
radiographically documented metastatic disease
boolean
C0027627 (UMLS CUI [1])
castration
Item
surgical or chemical castration
boolean
C0007347 (UMLS CUI [1])
psa
Item
prostate specific antigen (psa) > 5 ng/ml
boolean
C0138741 (UMLS CUI [1])
crpc
Item
castration resistant prostate cancer (crpc)
boolean
C4049338 (UMLS CUI [1])
taxane-based chemotherapy regimen
Item
one previous taxane-based chemotherapy regimen
boolean
C0392920 (UMLS CUI [1,1])
C0215136 (UMLS CUI [1,2])
performance status
Item
eastern cooperative group (ecog) performance status 0,1 or 2
boolean
C1520224 (UMLS CUI [1])
neutrophil count
Item
neutrophil count > 1,500/ul
boolean
C0200633 (UMLS CUI [1])
platelet count
Item
platelet count > 100,000/ul
boolean
C0005821 (UMLS CUI [1])
serum bilirubin
Item
serum bilirubin < 1.0 x upper limit normal (uln)
boolean
C1278039 (UMLS CUI [1])
serum alkaline phosphatase
Item
serum alkaline phosphatase < 1.5 x uln
boolean
C0201850 (UMLS CUI [1])
asparate aminotransferase/alanine aminotransferase
Item
asparate aminotransferase/alanine aminotransferase < 2.5 x uln
boolean
C3831581 (UMLS CUI [1])
albumin
Item
albumin > 2.5 g/dl
boolean
C0001924 (UMLS CUI [1])
serum creatinine
Item
serum creatinine < 1.5 x uln
boolean
C0201976 (UMLS CUI [1])
hormonal therapy
Item
prior hormonal therapy
boolean
C0279025 (UMLS CUI [1])
chemotherapy treatment
Item
chemotherapy treatment within 4 weeks of study entry
boolean
C0392920 (UMLS CUI [1])
contraception
Item
patient not employing adequate contraception
boolean
C0700589 (UMLS CUI [1])
comorbidity
Item
serious illness or medical conditions, specifically: uncontrolled congestive heart failure or history of myocardial infection or active angina pectoris within 6 months; active infectious process; chronic active liver disease, including chronic hepatitis b, c or cirrhosis
boolean
C0009488 (UMLS CUI [1])
anti-cancer treatment
Item
current anti-cancer treatment with any non-fda approved investigational drug
boolean
C2348568 (UMLS CUI [1])